Check Credit Score
Check Credit Score
HomeNewsIndia

Coronavirus impact: Chennai Petroleum Corporation writes down inventory of Rs 1,456 crore

In a filing to BSE, CPCL said the international prices of crude crashed on account of poor demand in the wake of COVID- 19 outbreak and the country wide lock-down affected its business operations.

June 05, 2020 / 09:26 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Indian Oil Group company Chennai Petroleum Corporation Ltd has recorded an inventory write down of Rs 1,456 crore due to the impact of COVID-19 on its operations, the city-based company said on Friday.

In a filing to BSE, CPCL said the international prices of crude crashed on account of poor demand in the wake of COVID- 19 outbreak and the country wide lock-down affected its business operations.

The lower demand for crude oil and petroleum products has impacted the prices and refining margins of the company, the company said.

"Due to the above reasons, finished goods, intermediates and raw material inventory have been valued at net realizable value/replacement costs as on March 31, 2020. This has resulted in significant inventory write down of Rs 1,456 crore," CPCL said.

Noting that the operations were scaled down at 60 percent, the management is expecting demand to improve in the next few months as economy opens up.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The lower demand and resultant inventory build-up has led to increased short term borrowings which is expected to normalise based on turn-around in demand situation and stabilisation of international crude oil prices, CPCL said.

The management has assessed the potential impact of coronavirus and expects 'no significant impact' on the continuity of the operations and there may be lower revenues and refinery throughput in near term, it added.

PTI

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347